| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Cell |
| Molecule Category: | UNKNOWN |
| UNII: | R0835E18NH |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | Somatic cell supplemental therapy |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 4 | D008545 | ClinicalTrials |
| Melanoma | 4 | D008545 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Liver Neoplasms | 1 | D008113 | ClinicalTrials |
| Mesothelioma | 1 | D008654 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298200 |
| FDA SRS | R0835E18NH |
CONTENTS